Herpesvirus of Turkeys Vaccine
In Stock
Boehringer’s Vaxxitek HVT+IBD vaccine is indicated for the protection of poultry against Herpesvirus of Turkeys.
INDICATIONS
- Target Species: Chickens (broilers, layers, and breeders).
- Disease Protection:
- Infectious Bursal Disease (IBD): Prevents mortality and reduces clinical signs/lesions, including standard and variant strains, with an onset of immunity at 2 weeks and duration up to 9 weeks.
- Marek’s Disease (MD): Reduces mortality, clinical signs, and lesions, with an onset of immunity at 4 days.
- Method of Administration: Subcutaneous injection (day-old) or in ovo vaccination (18-19 day embryos).
- Compatibility: Can be used in Vaxxitek HVT+IBD Vaccination Programs.
- Key Advantage: Protects against IBD while avoiding the “immunity gap” often associated with live IBD vaccines.
ADMINISTRATION
- In ovo: 0.05 mL per chicken egg at 18 days of embryonation using an automated egg injection machine.
- Subcutaneous: 0.2 mL per chicken at 1 day of age, injected under the loose skin at the back of the neck.
- Preparation: The vaccine is stored in liquid nitrogen and requires thawing (25°C – 30°C) and mixing into a sterile diluent, which should be used within one hour of preparation.
- Equipment: Use sterile, antiseptic-free equipment for injections.
